logo-primary.svg
bluepharma-logo-secondary-01.svg
WORLDWIDE . USA

Aggrega Pharma

usa.jpg
Who we are
Aggrega Pharma is committed to building a selective, valuable pipeline of generic products by leveraging the vast R&D, clinical and manufacturing experience and capabilities of its members.
The shareholders are 4 European companies: Bluepharma (Portugal), Rafarm (Greece), Substipharm (France) and Welding (Germany). Our Vision is to establish Aggrega Pharma as a premier partner to create a fully integrated pharmaceutical supply chain up to commercialization of drug product. We are continually looking to expand and increase our finished dose portfolio through collaborative working – a core principle at Aggrega Pharma. Our partnership combines flexible and innovative business models with collaborative process development to strengthen your products, while reducing your risk. Our partnership offering is supported by our network of development and commercial manufacturing facilities at Bluepharma (Portugal) and Rafarm (Greece) as well as our network of finished dose CDMOs in Europe, North America and Asia to meet your global product requirements.
Know more about us
more than
1200
combined employees
over
60
countries
over
100
global product launches
Aggrega Pharma
6 Arrow RD, STE 200
Ramsey, New Jersey 07446, USA
www.aggregapharma.com